MA50906A - Inhibiteurs d'immunoprotéasome - Google Patents
Inhibiteurs d'immunoprotéasomeInfo
- Publication number
- MA50906A MA50906A MA050906A MA50906A MA50906A MA 50906 A MA50906 A MA 50906A MA 050906 A MA050906 A MA 050906A MA 50906 A MA50906 A MA 50906A MA 50906 A MA50906 A MA 50906A
- Authority
- MA
- Morocco
- Prior art keywords
- immunoproteasome inhibitors
- immunoproteasome
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762587376P | 2017-11-16 | 2017-11-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50906A true MA50906A (fr) | 2020-09-23 |
Family
ID=64746633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050906A MA50906A (fr) | 2017-11-16 | 2018-11-14 | Inhibiteurs d'immunoprotéasome |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US11225493B2 (fr) |
| EP (1) | EP3710458B1 (fr) |
| JP (1) | JP7277457B2 (fr) |
| KR (1) | KR102625984B1 (fr) |
| CN (1) | CN111491938B (fr) |
| AU (1) | AU2018367515B2 (fr) |
| CA (1) | CA3080949C (fr) |
| CL (1) | CL2020001244A1 (fr) |
| CO (1) | CO2020007150A2 (fr) |
| EA (1) | EA202090900A1 (fr) |
| IL (1) | IL274523B2 (fr) |
| MA (1) | MA50906A (fr) |
| MX (2) | MX2020005046A (fr) |
| NZ (1) | NZ764393A (fr) |
| PH (1) | PH12020550580A1 (fr) |
| SG (1) | SG11202003867SA (fr) |
| TW (1) | TWI837104B (fr) |
| WO (1) | WO2019099582A1 (fr) |
| ZA (1) | ZA202002531B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3571208T3 (da) | 2017-01-18 | 2021-05-10 | Principia Biopharma Inc | Immunproteasominhibitorer |
| DK3700902T3 (en) | 2017-10-27 | 2023-05-22 | Boehringer Ingelheim Int | Inhibitorer af trpc6 |
| EP3710457B1 (fr) | 2017-11-16 | 2022-08-03 | Principia Biopharma Inc. | Inhibiteurs d'immunoprotéasome |
| WO2019099582A1 (fr) | 2017-11-16 | 2019-05-23 | Principia Biopharma Inc. | Inhibiteurs d'immunoprotéasome |
| WO2023061445A1 (fr) | 2021-10-14 | 2023-04-20 | 首药控股(北京)股份有限公司 | Dérivé d'acide boronique |
| JP2025521648A (ja) | 2022-06-30 | 2025-07-10 | プリンシピア バイオファーマ インコーポレイテッド | 環状ボロン酸エステル及びその使用 |
| TWI869142B (zh) * | 2022-12-27 | 2025-01-01 | 大陸商上海美悦生物科技發展有限公司 | 三肽環氧酮化合物、藥物組合物及其製備方法和用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US4963655A (en) | 1988-05-27 | 1990-10-16 | Mayo Foundation For Medical Education And Research | Boron analogs of amino acid/peptide protease inhibitors |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| IL111175A0 (en) | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| MXPA06009589A (es) | 2004-02-23 | 2007-03-26 | Tufts College | Inhibidores de dipeptidil peptidasa iv par regular el metabolismo de glucosa. |
| CA2791651C (fr) * | 2010-03-01 | 2019-08-20 | Onyx Therapeutics, Inc. | Composes pour inhibition de l'immunoproteasome |
| JP6129203B2 (ja) | 2011-12-22 | 2017-05-17 | アレス トレーディング ソシエテ アノニム | α−アミノボロン酸誘導体、選択性免疫プロテアソーム阻害剤 |
| EP3157909B1 (fr) | 2014-06-20 | 2021-04-07 | Principia Biopharma Inc. | Inhibiteurs de lmp7 |
| JP6662865B2 (ja) * | 2014-10-01 | 2020-03-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ボロン酸誘導体 |
| CN106588965A (zh) * | 2015-10-15 | 2017-04-26 | 北京大学 | 脲拟肽硼酸化合物及其药物组合物、制备方法和用途 |
| DK3571208T3 (da) | 2017-01-18 | 2021-05-10 | Principia Biopharma Inc | Immunproteasominhibitorer |
| EP3710457B1 (fr) | 2017-11-16 | 2022-08-03 | Principia Biopharma Inc. | Inhibiteurs d'immunoprotéasome |
| WO2019099582A1 (fr) | 2017-11-16 | 2019-05-23 | Principia Biopharma Inc. | Inhibiteurs d'immunoprotéasome |
-
2018
- 2018-11-14 WO PCT/US2018/061140 patent/WO2019099582A1/fr not_active Ceased
- 2018-11-14 KR KR1020207017251A patent/KR102625984B1/ko active Active
- 2018-11-14 EP EP18822543.7A patent/EP3710458B1/fr active Active
- 2018-11-14 AU AU2018367515A patent/AU2018367515B2/en active Active
- 2018-11-14 NZ NZ764393A patent/NZ764393A/en unknown
- 2018-11-14 US US16/764,136 patent/US11225493B2/en active Active
- 2018-11-14 IL IL274523A patent/IL274523B2/en unknown
- 2018-11-14 SG SG11202003867SA patent/SG11202003867SA/en unknown
- 2018-11-14 CN CN201880074665.3A patent/CN111491938B/zh active Active
- 2018-11-14 MA MA050906A patent/MA50906A/fr unknown
- 2018-11-14 MX MX2020005046A patent/MX2020005046A/es unknown
- 2018-11-14 EA EA202090900A patent/EA202090900A1/ru unknown
- 2018-11-14 CA CA3080949A patent/CA3080949C/fr active Active
- 2018-11-14 JP JP2020527042A patent/JP7277457B2/ja active Active
- 2018-11-16 TW TW107140806A patent/TWI837104B/zh active
-
2020
- 2020-05-07 PH PH12020550580A patent/PH12020550580A1/en unknown
- 2020-05-07 ZA ZA2020/02531A patent/ZA202002531B/en unknown
- 2020-05-12 CL CL2020001244A patent/CL2020001244A1/es unknown
- 2020-06-11 CO CONC2020/0007150A patent/CO2020007150A2/es unknown
- 2020-07-13 MX MX2022012825A patent/MX2022012825A/es unknown
-
2021
- 2021-11-16 US US17/527,514 patent/US11827656B2/en active Active
-
2023
- 2023-10-17 US US18/380,962 patent/US12312370B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283639A (en) | Kif18a inhibitors | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| IL269196A (en) | Novel inhibitors | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| EP3843714C0 (fr) | Inhibiteurs de cd73 | |
| IL269812A (en) | Ferroportin-inhibitor salts | |
| MA52413A (fr) | Inhibiteurs de cd73 | |
| EP3541932A4 (fr) | Inhibiteurs de crispr-cas9 | |
| EP3801503A4 (fr) | Inhibiteurs de sarm1 | |
| EP3626699A4 (fr) | Inhibiteur de ssao | |
| DK3571192T3 (da) | Jak1-selektive inhibitorer | |
| DK3442972T3 (da) | Bromdomænehæmmere | |
| EP3423435A4 (fr) | Inhibiteurs d'indoles mcl-1 substitués | |
| CU20160125A7 (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
| EP3787635A4 (fr) | Inhibiteurs de cd73 | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| EP3817736A4 (fr) | Inhibiteurs de pikfyve | |
| MA50906A (fr) | Inhibiteurs d'immunoprotéasome | |
| EP3801499A4 (fr) | Inhibiteurs de sarm1 | |
| DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
| EP3566532A4 (fr) | Configurations d'accès aléatoire | |
| IL262701A (en) | Enhancer of zeste homolog 2 inhibitors | |
| EP3600301A4 (fr) | Inhibiteurs de kdm4 |